VET
Vermilion Energy Inc.
VET lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
VET Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Weak |
VET's cash flow is currently strong, and its revenue and profitability are stable, but its balance sheet is weak.
VET PE Valuation
VET has no meaningful PE right now: it lost money over the past year.
VET Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for VET, with profitability improving.
VET Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.09 | -$1.24 |
| Q1 2026 | -$3.76 | -$3.62 |
| Q4 2025 | -$3.02 | -$2.82 |
| Q3 2025 | -$1.09 | +$2.49 |
| Q2 2025 | -$0.85 | +$2.71 |
| Q1 2025 | -$0.14 | +$2.53 |
| Q4 2024 | -$0.20 | +$0.88 |
| Q3 2024 | -$3.58 | -188% |
VET is still losing money, but far less than before: $2.09 per share over the past year, against $6.80 at its worst in late 2020.
VET Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $364.9M | +9.9% |
| Q1 2026 | $343.9M | -16% |
| Q4 2025 | $302.1M | -17% |
| Q3 2025 | $296.8M | -16% |
| Q2 2025 | $332M | +24% |
| Q1 2025 | $411.4M | +7.1% |
| Q4 2024 | $362.6M | -8.1% |
| Q3 2024 | $354.7M | -4.2% |
VET's revenue is recovering but still below its 2022 peak: $365M last quarter, up 9.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 26% | +17 points |
| Q1 2026 | 21% | +1.7 points |
| Q4 2025 | -0.8% | -17 points |
| Q3 2025 | 53% | +42 points |
| Q2 2025 | 9.2% | +4.5 points |
| Q1 2025 | 19% | +7.8 points |
| Q4 2024 | 16% | +10 points |
| Q3 2024 | 11% | +11 points |
VET's operating margin was 26% last quarter, up 17 points from the same quarter a year ago.
VET Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $43.1M | +145% |
| Q1 2026 | $65.7M | -4.9% |
| Q4 2025 | -$42.4M | -1005% |
| Q3 2025 | $170.7M | +1987% |
| Q2 2025 | $17.6M | -84% |
| Q1 2025 | $69.1M | -40% |
| Q4 2024 | $4.7M | -98% |
| Q3 2024 | $8.2M | +$15.5M |
VET still generates free cash flow, though less than at its 2022 peak: $237M over the past year.
VET Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.1% | +3.2M shares |
| 1 year | +0.1% | +162K shares |
| 3 years | -6.8% | -11.4M shares |
| 5 years | -5.5% | -9.1M shares |
| Available history | +0.4% | +686K shares |
VET has 156M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $3.8M |
| Q1 2026 | $3.3M |
| Q4 2025 | $4.6M |
| Q3 2025 | $4.4M |
| Q2 2025 | $4.4M |
| Q1 2025 | $11.7M |
| Q4 2024 | $12.4M |
| Q3 2024 | $28.2M |
VET spent $16M buying back its own shares over the past year, down 71% from the year before.
VET Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.2x | High |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 2.1x | Moderate |
| Q3 2025 | 1.4x | Healthy |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 2.7x | Moderate |
| Q4 2024 | 1.2x | Healthy |
| Q1 2024 | 4.0x | Elevated |
VET's net debt is about 4.2 years of its operating earnings (EBITDA), up from 2.0 years a year ago.
VET Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.0 | Neutral |
| Stochastic | 36.9 | Neutral |
VET's weekly RSI is 46 (neutral) and its Stochastic is 37 (neutral).
VET PE vs Energy Sector
| Metric | VET | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
VET has no meaningful PE right now: it lost money over the past year.
VET Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 10% below |
| 20 week MA | $11.7 | 7.2% below |
| 50 week MA | $11.2 | 2.4% below |
| 100 week MA | $9.54 | 14% above |
| 200 week MA | $10.8 | 0.6% above |
VET has slipped below its 8-, 20- and 50-week averages, though it's still 0.6% above its 200-week average.
VET Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.4 | $4.46 | -73% |
| 2021 | $4.46 | $12.8 | +187% |
| 2022 | $12.8 | $18.0 | +41% |
| 2023 | $18.0 | $12.1 | -33% |
| 2024 | $12.1 | $8.92 | -26% |
| 2025 | $8.92 | $8.18 | -8.3% |
| 2026 YTD | $8.18 | $10.9 | +33% |
VET has finished three years in a row lower, and it's up 33% so far in 2026.